Cargando…

Checkpoint inhibitor pneumonitis mimicking COVID-19 infection during the COVID-19 pandemic

Detalles Bibliográficos
Autores principales:	Chang, Hsu-Liang, Wei, Po-Ju, Wu, Kuan-Li, Huang, Hung-Ling, Yang, Chih-Jen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834130/ https://www.ncbi.nlm.nih.gov/pubmed/32576385 http://dx.doi.org/10.1016/j.lungcan.2020.06.013

Ejemplares similares

A CASE OF PNEUMONIC TULAREMIA MIMICKING COVID-19
por: MIR, MAHNOOR, et al.
Publicado: (2021)

Rituximab-induced pneumonitis mimicking miliary tuberculosis
por: Yao, Chih-Wei, et al.
Publicado: (2013)

Rifampicin-Induced Pneumonitis Mimicking Severe COVID-19 Pneumonia Infection
por: Ata, Fateen, et al.
Publicado: (2020)

Pneumonitis from immune checkpoint inhibitors and COVID-19: current concern in cancer treatment
por: Rossi, Ernesto, et al.
Publicado: (2020)

Immune checkpoint inhibitor-related pneumonitis and COVID-19: a case-matched comparison of CT findings
por: Picasso, Riccardo, et al.
Publicado: (2023)

Chronic immune checkpoint inhibitor pneumonitis
por: Naidoo, Jarushka, et al.
Publicado: (2020)

Correction: Chronic immune checkpoint inhibitor pneumonitis
Publicado: (2020)

Differentiation of COVID-19 Pneumonitis and ICI Induced Pneumonitis
por: Dumoulin, Daphne W., et al.
Publicado: (2020)

Deep Learning Algorithm Trained with COVID-19 Pneumonia Also Identifies Immune Checkpoint Inhibitor Therapy-Related Pneumonitis
por: Mallio, Carlo Augusto, et al.
Publicado: (2021)

The epidemiological features of pediatric viral respiratory infection during the COVID-19 pandemic in Taiwan
por: Hsu, Hao-Ting, et al.
Publicado: (2022)

Pretreatment Lung Function and Checkpoint Inhibitor Pneumonitis in NSCLC
por: Reuss, Joshua E., et al.
Publicado: (2021)

Comprehensive Analysis of the Immune Microenvironment in Checkpoint Inhibitor Pneumonitis
por: Lin, Xinqing, et al.
Publicado: (2022)

P34.05 Three Birds, One Stone: IVIG Use in Hypogammaglobulinemia, Checkpoint Inhibitor Pneumonitis, and Persistent COVID-19
por: Olson, E., et al.
Publicado: (2021)

Pembrolizumab-related pneumonitis in a patient with COVID-19 infection
por: Ponnalagu, Venkataganesan, et al.
Publicado: (2022)

Pulse corticosteroid therapy in the treatment of steroid-refractory immune checkpoint inhibitor-related pneumonitis: Case report and review
por: Lai, Kuan-Chang, et al.
Publicado: (2022)

Risk factors and immunomodulators use in steroid-refractory checkpoint inhibitor pneumonitis
por: Li, Yanlin, et al.
Publicado: (2023)

COVID-19, A and Hypersensitivity Pneumonitis
por: Joob, Beuy, et al.
Publicado: (2020)

COVID-19 VACCINE-RELATED PNEUMONITIS
por: TSENG, CHENGTIN, et al.
Publicado: (2022)

Need for Caution in the Diagnosis of Radiation Pneumonitis During the COVID-19 Pandemic
por: Shaverdian, Narek, et al.
Publicado: (2020)

Infection control measures of a Taiwanese hospital to confront the COVID‐19 pandemic
por: Chang, Ya‐Ting, et al.
Publicado: (2020)

Clinical diagnosis and treatment of immune checkpoint inhibitor‐associated pneumonitis
por: Wang, Hanping, et al.
Publicado: (2019)

Immune checkpoint inhibitors in cancer patients with COVID-19
por: Pan, Yun, et al.
Publicado: (2023)

Case Report of Amiodarone-associated Allergic Pneumonitis Amidst the COVID-19 Pandemic
por: Azraai, M., et al.
Publicado: (2021)

Reply: COVID-19, A and Hypersensitivity Pneumonitis
por: Shin, Hyoung-Shik
Publicado: (2020)

OSIMERTINIB PNEUMONITIS MASQUERADING AS COVID-19 PNEUMONIA
por: ALHALABI, ELIANE, et al.
Publicado: (2021)

HLA Expression Correlates to the Risk of Immune Checkpoint Inhibitor-Induced Pneumonitis
por: Correale, Pierpaolo, et al.
Publicado: (2020)

Diffuse pneumonitis from coronavirus HKU1 on checkpoint inhibitor therapy
por: Serzan, Michael T, et al.
Publicado: (2020)

Long-term outcomes in patients with immune checkpoint inhibitor induced pneumonitis
por: Davis Puente, Andrea, et al.
Publicado: (2023)

Identification and prediction of immune checkpoint inhibitors-related pneumonitis by machine learning
por: Gong, Li, et al.
Publicado: (2023)

Changing Epidemiology of Respiratory Tract Infection during COVID-19 Pandemic
por: Tang, Hung-Jen, et al.
Publicado: (2022)

COVID-19 PNEUMONIA COMPLICATED BY CMV PNEUMONITIS FOLLOWING TREATMENT WITH AN IL-6 INHIBITOR
por: PANDIAN, ELIZABETH, et al.
Publicado: (2021)

Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor
por: Wang, Wenxian, et al.
Publicado: (2022)

Radiation-Induced Pneumonitis in the Era of the COVID-19 Pandemic: Artificial Intelligence for Differential Diagnosis
por: Giordano, Francesco Maria, et al.
Publicado: (2021)

Risk factors for immune checkpoint inhibitor-related pneumonitis in non-small cell lung cancer
por: Chao, Yencheng, et al.
Publicado: (2022)

Clinical features, diagnostic challenges, and management strategies in checkpoint inhibitor-related pneumonitis
por: Chuzi, Sarah, et al.
Publicado: (2017)

Pneumonitis Induced by Immune Checkpoint Inhibitors: From Clinical Data to Translational Investigation
por: Zhu, Shicong, et al.
Publicado: (2020)

Radiation Versus Immune Checkpoint Inhibitor Associated Pneumonitis: Distinct Radiologic Morphologies
por: Chen, Xuguang, et al.
Publicado: (2021)

Insights into Potential Pathogenesis and Treatment Options for Immune-Checkpoint Inhibitor-Related Pneumonitis
por: Ando, Hiroyuki, et al.
Publicado: (2021)

Treatment of steroid‐resistant checkpoint inhibitor pneumonitis with pirfenidone: A case report
por: Miao, Kang, et al.
Publicado: (2021)

Proposed clinical phases for the improvement of personalized treatment of checkpoint inhibitor–related pneumonitis
por: Zhou, Chengzhi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tn89s9p4bb06cmmqtj3b25t16m